SW · SKAN.SW
SKAN Group AG
- Sector
- Healthcare · Medical - Instruments & Supplies
- Headquarters
- Allschwil 4123
- Website
- skan.com
Price · as of 2024-12-31
$45.60
Market cap 1.15B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $81.15 | +77.96% |
| Intrinsic Value(DCF) | $31.50 | -30.92% |
| Graham-Dodd Method(GD) | $12.10 | -73.46% |
| Graham Formula(GF) | $35.16 | -22.89% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | $10.37 | $0.00 | |||
| 2014 | $8.94 | $37.29 | |||
| 2015 | $0.00 | $454.23 | |||
| 2016 | $14.76 | $0.00 | |||
| 2017 | $15.84 | $0.00 | |||
| 2018 | $11.91 | $29.48 | |||
| 2019 | $19.27 | $65.78 | |||
| 2020 | $6.14 | $2,074.08 | |||
| 2021 | $61.73 | $97.04 | $20,830.00 | $4.24 | $24.66 |
| 2022 | $67.90 | $85.20 | $3,839.30 | $7.62 | $21.57 |
| 2023 | $78.00 | $118.28 | $216.14 | $9.63 | $26.98 |
| 2024 | $73.27 | $81.15 | $74.95 | $12.10 | $35.16 |
AI valuation
Our deep-learning model estimates SKAN Group AG's (SKAN.SW) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $81.15
- Current price
- $45.60
- AI upside
- +77.96%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$31.50
-30.92% upside
Graham-Dodd
$12.10
-73.46% upside
Graham Formula
$35.16
-22.89% upside
About SKAN Group AG
SKAN Group AG provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Asia, Europe, the Americas, and internationally. It operates in two segments: Equipment and Solutions (E&S) and Services and Consumables (S&C). The E&S segment offers mission-critical solutions for the pharmaceutical production, including isolators, integrated automated systems, and aseptic filling systems and solutions, as well as laboratory and cleanroom equipment. The S&C segment provides life cycle support and ready-to-use consumables, as well as customer- specific and digital solutions. The company was formerly known as BV Holding AG and changed its name to SKAN Group AG in October 2021. SKAN Group AG was founded in 1968 and is headquartered in Allschwil, Switzerland.
- CEO
- Jonas Greutert
- Employees
- 1.38K
- Beta
- 0.88
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($31.50 ÷ $45.60) − 1 = -30.92% (DCF, example).